Close Menu

Nobel Prize-winning scientist Paul Greengard has discovered a new way for researchers to target Alzheimer's disease. Beta amyloid, the plaque that builds up in the brains of Alzheimer's patients, has long been targeted by researchers. Now Greengard has discovered a new protein that is needed to make beta amyloid, reports the New York Times' Gina Kolata. Many Alzheimer's drugs currently being studied target the enzyme gamma secretase, which helps make beta amyloid.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.

According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.

The US National Institutes of Health has a new initiative to address structural racism in biomedical research.

In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.